The GLP-1 Weight-Loss Drug Boom: What the “Unstoppable Market” Means for You

The field of obesity treatment is evolving fast. According to Morgan Stanley, the global market for weight-loss drugs may grow to $150 billion by 2035, with over 140 new medications in development and a projected 27% annual growth through 2028. It is called an “unstoppable market.”[1]

But what does that really mean for you? The person who has struggled with weight, digestion, diets, or stigma for years?

It means everything. It means opportunities. In the next 24 months we will see a couple of new exciting launches in the weight loss market mainly with oral drugs. Around year 2030 there will be an explosion of new drugs – and hence opportunities – to benefit patients. Many will be based on GLP-1 – alone or in combination with one or two other molecules. This leads to new opportunities for all the people struggling with weight loss.

What “Unstoppable” Really Means for You

When people say the obesity drug market is “unstoppable,” it can sound distant like it is about Wall Street projections and pharma pipelines. But at its heart, this momentum is about something much more personal.

It is about you finally getting the care, opportunity, support, and recognition you have deserved all along. It is about the many new treatments being developed to help you reach your goals.

You Are Finally Taken Seriously

If you have lived with obesity and have been struggling with weight, you have probably felt judged. Dismissed. Told it is your fault.

But now, leading doctors, researchers, and policymakers are calling obesity what it truly is: a complex medical condition, not a simple lack of willpower. This shift means your story matters and your struggle is valid. That is why the many new drugs expected to enter the market over the next five years offer promising opportunities and support to help you become “unstoppable.”

You Have Real Tools, Not Just Advice

For years, treatment options were limited to “eat less, move more.” Now, science is offering something more: medications that target appetite and metabolism, helping to reduce cravings. Tools that actually work with your biology, not against it.
You finally have a chance to succeed, not just try harder.

You Are Not on This Journey Alone Anymore

More countries are approving these treatments. More doctors are prescribing them. And a growing number of people are stepping forward and saying: “This is the first time I’ve felt hope.”

Losing weight and keeping it off is very difficult. It is a challenging journey where you need support.

It Is About Your Whole Life, Not Just Your Weight

The benefits go far beyond the scale. We are talking about fewer heart attacks and cardiovascular support. Better sleep. Lower blood sugar. A longer, more active life. This is about being there for your family and friends. Reclaiming energy. Feeling confident in your body. Living well. Being healthy and happy.

“Unstoppable” means that better care, better tools, and better outcomes are finally moving toward you, not away from you.

The Side Effect Gap

Despite the progress, many patients still face one major challenge: side effects.

• Nausea.
• Bloating.
• Constipation.
• Reflux.

As per the UBS Evidence Lab survey:

• 51% of patients who stopped their GLP‑1 treatment did so because of side effects.
• 47% said they’d consider paying for a product to help with those symptoms [2].
  

Side effects are a real struggle. They not only affect your quality of life but also make the weight loss journey harder, eventually pushing some to stop treatment altogether.

Where Forte80™ Comes In

At Azento Health, we believe that weight loss should not come at the cost of comfort.
That is why we created Forte80™, a gut microbiome-support formula that works with your GLP1 treatment, not against it. Forte80™ helps you:

• Ease bloating, reflux, and constipation.
• Support your microbiome during dietary change, because your gut plays a crucial role in weight management.
• Stay consistent with your medication - so results can build.

With 80 billion CFUs and four targeted strains, Forte80™ gives your gut the resilience it needs during weight loss.

Because comfort, health and happiness is not optional. It is essential.

Final Thought: You Deserve Real Treatment And Real Support

This is your moment. The science is changing. The world is catching up. And your care is becoming what it always should have been: respectful, evidence-based, and empowering.

If you are on or considering a GLP1 therapy, do not settle for just losing weight.
You deserve to feel well on the journey. Forte80™ helps make that possible.

1. Morgan Stanley Research. Obesity Drugs’ Exponential Growth. Morgan Stanley. 2025.
2. UBS GLP-1 Consumer Survey, 2024, Evidence Lab survey of 500 past and present GLP-1 users in the US. UBS Investment Bank. 2024.